Lannett , Inc. EBIT

As of the most recent data (March 2023), LCINQ shows a EBIT of $-57M. That compares with $-51M in the prior-year period — down 10.4% year over year. That is below the Healthcare sector average of $2T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LCINQ's EBIT is now $-57M (was $-51M) — a 10.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lannett , Inc. is outperforming or lagging.

The Healthcare sector average EBIT is about $2T. Lannett , Inc. is at $-57M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how LCINQ stacks up against individual peers as well.

Tracking LCINQ's ebit over time shows whether Lannett , Inc. is scaling, shrinking, or reshaping that part of the business. The current reading is $-57M That compares with $-51M in the prior-year period — down 10.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Lannett , Inc.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-57M) with ownership activity and broader fundamentals.